Myeloma Tumor Cell Growth And Survival Regulated By Human C-Reactive Protein

September 12th, 2007 | Category: Cancer

Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target

for cancer treatment.CRP is a protein that is made in the liver and secreted systemically during the process of inflammation in response to the inflammatory cytokine IL-6. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Blocking A individual Protein Proves Toxic To Myeloma Cells In Laboratory Studies
  • Study Details Regulation Of Vital Tumor Suppressor Gene P53
  • Signaling Protein For Multiple Myeloma Identified, Findings May aftereffect In New Therapeutic Target
  • Prognostic Impact Of Postoperative C-Reactive Protein Level In Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
  • Method To Duplicate Primitive Stem Cells And Prevent Cell Differentiation Discovered At USC

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.